MedTrace Logo

Clinical Pediatric Pneumonia Score in Critically Ill Children

NCT02139384 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2017-04-25

No results posted yet for this study

Summary

The purpose of the study is to create a clinical pneumonia tool that can be used to predict the cause of community-acquired pneumonia, which is a lung infection that began outside of the hospital in critically ill children therefore limiting unnecessary antibiotic use. The investigators will enroll critically ill children admitted with acute respiratory failure and suspected pneumonia. Each patient will receive a clinical pneumonia score blinded from culture and respiratory viral panel results. All care after samples obtained will be at the discretion of the PICU team. The investigators believe that our clinical pneumonia scale with procalcitonin will accurately designate viral from bacterial etiologies.

Conditions

  • Community Acquired Pneumonia

Sponsors & Collaborators

  • Loma Linda University

    lead OTHER

Principal Investigators

  • Cynthia Tinsley, M.D. · Loma Linda University

Eligibility

Min Age
1 Day
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02139384 on ClinicalTrials.gov